Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Transfection of Vitamin D3-Induced Tolerogenic Dendritic Cells for the Silencing of Potential Tolerogenic Genes. Identification of CSF1R-CSF1 Signaling as a Glycolytic Regulator.
Mansilla MJ, González-Larreategui I, Figa-Martín N, Barallat J, Fondelli F, Sellés-Rius A, Quirant-Sánchez B, Teniente-Serra A, Martínez-Cáceres E. Mansilla MJ, et al. Int J Mol Sci. 2021 Jul 8;22(14):7363. doi: 10.3390/ijms22147363. Int J Mol Sci. 2021. PMID: 34298983 Free PMC article.
Cell-based Tolerogenic Therapy, Experience from Animal Models of Multiple Sclerosis, Type 1 Diabetes and Rheumatoid Arthritis.
Stojanovic I, Dimitrijevic M, Vives-Pi M, Mansilla MJ, Pujol-Autonell I, Rodríguez-Fernandez S, Palova-Jelínkova L, Funda DP, Gruden-Movsesijan A, Sofronic-Milosavljevic L, Hilkens CMU, Martinez-Caceres E, Miljkovic D. Stojanovic I, et al. Among authors: mansilla mj. Curr Pharm Des. 2017;23(18):2623-2643. doi: 10.2174/1381612823666170214120708. Curr Pharm Des. 2017. PMID: 28201972 Review.
Monitoring CD49d Receptor Occupancy: A Method to Optimize and Personalize Natalizumab Therapy in Multiple Sclerosis Patients.
Puñet-Ortiz J, Hervás-García JV, Teniente-Serra A, Cano-Orgaz A, Mansilla MJ, Quirant-Sánchez B, Navarro-Barriuso J, Fernández-Sanmartín MA, Presas-Rodríguez S, Ramo-Tello C, Martínez-Cáceres EM. Puñet-Ortiz J, et al. Among authors: mansilla mj. Cytometry B Clin Cytom. 2018 Mar;94(2):327-333. doi: 10.1002/cyto.b.21527. Epub 2017 Apr 17. Cytometry B Clin Cytom. 2018. PMID: 28378895 Free article.
Liposome-based immunotherapy against autoimmune diseases: therapeutic effect on multiple sclerosis.
Pujol-Autonell I, Mansilla MJ, Rodriguez-Fernandez S, Cano-Sarabia M, Navarro-Barriuso J, Ampudia RM, Rius A, Garcia-Jimeno S, Perna-Barrull D, Martinez-Caceres E, Maspoch D, Vives-Pi M. Pujol-Autonell I, et al. Among authors: mansilla mj. Nanomedicine (Lond). 2017 Jun;12(11):1231-1242. doi: 10.2217/nnm-2016-0410. Nanomedicine (Lond). 2017. PMID: 28593827 Free article.
Monitoring T-Cell Responses in Translational Studies: Optimization of Dye-Based Proliferation Assay for Evaluation of Antigen-Specific Responses.
Ten Brinke A, Marek-Trzonkowska N, Mansilla MJ, Turksma AW, Piekarska K, Iwaszkiewicz-Grześ D, Passerini L, Locafaro G, Puñet-Ortiz J, van Ham SM, Hernandez-Fuentes MP, Martínez-Cáceres EM, Gregori S. Ten Brinke A, et al. Among authors: mansilla mj. Front Immunol. 2017 Dec 21;8:1870. doi: 10.3389/fimmu.2017.01870. eCollection 2017. Front Immunol. 2017. PMID: 29312346 Free PMC article.
Corrigendum: Monitoring T-Cell Responses in Translational Studies: Optimization of Dye-Based Proliferation Assay for Evaluation of Antigen-Specific Responses.
Ten Brinke A, Marek-Trzonkowska N, Mansilla MJ, Turksma AW, Piekarska K, Iwaszkiewicz-Grześ D, Passerini L, Locafaro G, Puñet-Ortiz J, van Ham SM, Hernandez-Fuentes MP, Martínez-Cáceres EM, Gregori S. Ten Brinke A, et al. Among authors: mansilla mj. Front Immunol. 2018 Feb 22;9:343. doi: 10.3389/fimmu.2018.00343. eCollection 2018. Front Immunol. 2018. PMID: 29493663 Free PMC article.
41 results